Cirtran Stock Performance
| CIRX Stock | USD 0.02 0 4.17% |
CirTran holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.98, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CirTran will likely underperform. Use CirTran value at risk, as well as the relationship between the kurtosis and market facilitation index , to analyze future returns on CirTran.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CirTran are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, CirTran showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 108.1 K | |
| Total Cashflows From Investing Activities | -3798.00 |
CirTran |
CirTran Relative Risk vs. Return Landscape
If you would invest 1.80 in CirTran on October 29, 2025 and sell it today you would earn a total of 0.50 from holding CirTran or generate 27.78% return on investment over 90 days. CirTran is currently generating 1.9551% in daily expected returns and assumes 19.6142% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CirTran, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CirTran Target Price Odds to finish over Current Price
The tendency of CirTran Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.02 | 90 days | 0.02 | about 64.32 |
Based on a normal probability distribution, the odds of CirTran to move above the current price in 90 days from now is about 64.32 (This CirTran probability density function shows the probability of CirTran Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 2.98 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, CirTran will likely underperform. In addition to that CirTran has an alpha of 2.0049, implying that it can generate a 2.0 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CirTran Price Density |
| Price |
Predictive Modules for CirTran
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CirTran. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CirTran Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CirTran is not an exception. The market had few large corrections towards the CirTran's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CirTran, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CirTran within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.00 | |
β | Beta against Dow Jones | 2.98 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.11 |
CirTran Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CirTran for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CirTran can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CirTran is way too risky over 90 days horizon | |
| CirTran has some characteristics of a very speculative penny stock | |
| CirTran appears to be risky and price may revert if volatility continues | |
| CirTran has high likelihood to experience some financial distress in the next 2 years | |
| CirTran currently holds 2.53 M in liabilities. CirTran has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist CirTran until it has trouble settling it off, either with new capital or with free cash flow. So, CirTran's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CirTran sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CirTran to invest in growth at high rates of return. When we think about CirTran's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.92 M. Net Loss for the year was (838.47 K) with profit before overhead, payroll, taxes, and interest of 1.9 M. |
CirTran Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CirTran Pink Sheet often depends not only on the future outlook of the current and potential CirTran's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CirTran's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 144.3 M | |
| Cash And Short Term Investments | 5472.00 |
CirTran Fundamentals Growth
CirTran Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CirTran, and CirTran fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CirTran Pink Sheet performance.
| Return On Asset | -0.16 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | (0.18) % | |||
| Current Valuation | 3.26 M | |||
| Shares Outstanding | 4.95 M | |||
| Price To Earning | 0.36 X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 2.92 M | |||
| EBITDA | 837.96 K | |||
| Cash And Equivalents | 6.85 K | |||
| Total Debt | 2.53 M | |||
| Book Value Per Share | (8.40) X | |||
| Cash Flow From Operations | 344.46 K | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 1.46 M | |||
About CirTran Performance
Evaluating CirTran's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if CirTran has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CirTran has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
CirTran Corporation provides manufacturing, marketing, distribution, and technology services for consumer products, including tobacco products, medical devices, and beverages worldwide. The company was incorporated in 1987 and is based in Las Vegas, Nevada. CIRTRAN CORP operates under Conglomerates classification in the United States and is traded on OTC Exchange. It employs 3 people.Things to note about CirTran performance evaluation
Checking the ongoing alerts about CirTran for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CirTran help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CirTran is way too risky over 90 days horizon | |
| CirTran has some characteristics of a very speculative penny stock | |
| CirTran appears to be risky and price may revert if volatility continues | |
| CirTran has high likelihood to experience some financial distress in the next 2 years | |
| CirTran currently holds 2.53 M in liabilities. CirTran has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist CirTran until it has trouble settling it off, either with new capital or with free cash flow. So, CirTran's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CirTran sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CirTran to invest in growth at high rates of return. When we think about CirTran's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.92 M. Net Loss for the year was (838.47 K) with profit before overhead, payroll, taxes, and interest of 1.9 M. |
- Analyzing CirTran's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CirTran's stock is overvalued or undervalued compared to its peers.
- Examining CirTran's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CirTran's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CirTran's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CirTran's pink sheet. These opinions can provide insight into CirTran's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CirTran Pink Sheet Analysis
When running CirTran's price analysis, check to measure CirTran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CirTran is operating at the current time. Most of CirTran's value examination focuses on studying past and present price action to predict the probability of CirTran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CirTran's price. Additionally, you may evaluate how the addition of CirTran to your portfolios can decrease your overall portfolio volatility.